CRIS Current Research Information System

SOLLAZZO, DARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.961
AS - Asia 1.564
EU - Europa 1.230
AF - Africa 90
SA - Sud America 60
OC - Oceania 7
Totale 4.912
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.938
VN - Vietnam 489
SG - Singapore 399
CN - Cina 359
GB - Regno Unito 300
SE - Svezia 212
IT - Italia 201
DE - Germania 159
HK - Hong Kong 96
IN - India 87
FR - Francia 78
IE - Irlanda 58
RU - Federazione Russa 58
BR - Brasile 40
FI - Finlandia 33
ZA - Sudafrica 26
EE - Estonia 23
JP - Giappone 23
TG - Togo 23
BG - Bulgaria 21
CA - Canada 20
JO - Giordania 19
NL - Olanda 18
UA - Ucraina 17
BE - Belgio 16
CI - Costa d'Avorio 15
CH - Svizzera 13
KR - Corea 12
PH - Filippine 12
NG - Nigeria 11
TW - Taiwan 10
TH - Thailandia 9
AR - Argentina 8
IR - Iran 8
MY - Malesia 8
AU - Australia 6
BD - Bangladesh 5
TR - Turchia 5
AT - Austria 4
DZ - Algeria 4
EC - Ecuador 4
ID - Indonesia 4
IQ - Iraq 4
PL - Polonia 4
SA - Arabia Saudita 4
LB - Libano 3
MX - Messico 3
RO - Romania 3
CZ - Repubblica Ceca 2
EG - Egitto 2
ES - Italia 2
ET - Etiopia 2
IL - Israele 2
NO - Norvegia 2
PE - Perù 2
PK - Pakistan 2
SC - Seychelles 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BO - Bolivia 1
CG - Congo 1
CO - Colombia 1
DK - Danimarca 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
KE - Kenya 1
LT - Lituania 1
LY - Libia 1
MA - Marocco 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
PY - Paraguay 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 4.912
Salva come PNG Salva come JPEG
Città #
Singapore 262
Southend 250
Chandler 224
Ashburn 204
Fairfield 194
Dong Ket 109
Woodbridge 99
Hong Kong 95
San Jose 93
Houston 91
Seattle 89
Ho Chi Minh City 84
Cambridge 82
Wilmington 70
Hanoi 67
Ann Arbor 63
Beijing 62
Princeton 61
Dublin 58
Santa Clara 54
Bologna 43
Boardman 34
Cornaredo 32
Lauterbourg 29
Helsinki 27
Redmond 26
Bremen 25
Westminster 25
Lomé 23
Nanjing 23
Los Angeles 21
Sofia 21
Jinan 20
Tokyo 20
Amman 19
Padova 19
Berlin 18
New York 18
Turin 17
Brussels 16
Abidjan 15
Hefei 15
Milan 13
Munich 13
Redondo Beach 13
Saint Petersburg 12
Shenyang 12
Abeokuta 11
Changsha 11
Dallas 11
Medford 11
Da Nang 10
Falls Church 10
Haiphong 10
Hyderabad 10
Bern 9
Florence 9
Frankfurt am Main 9
Nanchang 9
San Diego 9
Buffalo 8
Council Bluffs 8
Guangzhou 8
Kuala Lumpur 7
London 7
Redwood City 7
Seoul 7
São Paulo 7
Fremont 6
Hangzhou 6
Hebei 6
Orem 6
Shanghai 6
Suzhou 6
Tianjin 6
Turku 6
Zhengzhou 6
Montreal 5
Rome 5
Winnipeg 5
Chicago 4
Des Moines 4
Jiaxing 4
Leawood 4
Nuremberg 4
Paris 4
Pune 4
Quận Bình Thạnh 4
Stockholm 4
Taiyuan 4
Xi'an 4
Zanjan 4
Andover 3
Baltimore 3
Bangkok 3
Basingstoke 3
Biên Hòa 3
Brooklyn 3
Can Tho 3
Caprino Veronese 3
Totale 3.209
Salva come PNG Salva come JPEG
Nome #
Circulating calreticulin is increased in myelofibrosis: Correlation with interleukin-6 plasma levels, bone marrow fibrosis, and splenomegaly 257
CIRCULATING PLATELET AND MEGAKARYOCYTE-DERIVED MICROPARTICLES OF JAK2V617F MUTATED PATIENTS WITH MYELOFIBROSIS ARE DISREGULATED: A NOVEL LIQUID BIOPSY TOOL OF RESPONSE TO RUXOLITINIB? 218
CIRCULATING CD34+ STEM/PROGENITOR CELLS FROM TRIPLE NEGATIVE PATIENTS WITH MYELOFIBROSIS SHOW DIFFERENT NUMBER, GENE EXPRESSION PROFILE AND IN VITRO RESPONSE TO INFLAMMATORY STIMULI AS COMPARED WITH THE JAK2(V617F) MUTATED COUNTERPARTS 212
Bleeding in essential thrombocythaemia: a retrospective analysis on 565 patients 207
Mobilized Peripheral Blood versus Cord Blood: Insight into the distinct role of proinflammatory cytokines on survival, clonogenic ability, and migration of CD34+ cells 204
STUDIO DELLA FUNZIONE E DEL PROFILO DEI MICRORNA IN MICROPARTICELLE CIRCOLANTI ISOLATE DA PAZIENTI ‘TRIPLI NEGATIVI’ E JAK2V617F MUTATI CON MIELOFIBROSI 200
Circulating Platelet Vs Megakaryocyte-Derived Microparticles Identify Myelofibrosis Patients with JAK2V617F Mutation, High Disease Burden and Ruxolitinib Response 198
Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis 192
Crucial factors of the inflammatory microenvironment (IL-1β/ TNF-α/TIMP-1) promote the maintenance of the malignant hemopoietic clone of myelofibrosis: an in vitro study 185
TOWARD THE IDENTIFICATION OF A MICRORNA-BASED SIGNATURE OF CIRCULATING MICROPARTICLES FROM TRIPLE NEGATIVE AND JAK2(V617F) MUTATED PATIENTS WITH MYELOFIBROSIS 184
Circulating CD4+CD25-Foxp3+ cells are increased in patients with immune thrombocytopenia 183
Decreased expression of indoleamine 2,3-dioxygenase 1 in dendritic cells contributes to impaired regulatory T cell development in immune thrombocytopenia 179
Mutations in JAK2 and Calreticulin genes are associated with specific alterations of the immune system in myelofibrosis 179
Molecular and functional characterization of CD133+stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cells 179
Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function 175
Crucial Factors of the Inflammatory Microenvironment (IL-1 beta/TNF-alpha/TIMP-1) Promote Maintenance of the Malignant Hemopoietic Clone of Myelofibrosis By Stimulating the in Vitro Survival/Proliferation/Migration of Circulating CD34+ stem/Progenitor Cells 167
CD 133+ stem cells for the treatment of end stage liver disease. 160
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 159
The choice of second-line therapy in steroid-resistant immune thrombocytopenia: Role of platelet kinetics in a single-centre long-term study 139
MYH9-related thrombocytopenia and intracranial bleedings: a complex clinical/surgical management and review of the literature 137
Platelet fluctuations during thrombopoietin-receptor agonist treatment: correlation with platelet apoptosis 130
Molecular profile of CD34+ stem/progenitor cells according to JAK2V617F mutation status in essential thrombocythemia. 129
Risk factors for infections in myelofibrosis: role of disease status and treatment. A multicenter study of 507 patients 122
The CD47 pathway is deregulated in human immune thrombocytopenia 113
null 107
Circulating CD4+CD161+CD196+ Th17 cells are not increased in immune thrombocytopenia 107
CD133+ hematopoietic stem cells reinfusion in end-stage liver disease (ESLD): final results of a phase I clinical trial 106
CD133+ stem cells for the treatment of end-stage liver disease 104
null 98
null 96
Have splenectomy rate and main outcomes of ITP changed after the introduction of new treatments? A monocentric study in the outpatient setting during 35 years 91
Reinfusion of highly purified CD133+ stem cells in patients with end-stage liver disease (ESLD): final results of a phase I clinical trial 87
Totale 5.004
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.340
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.340
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021290 0 0 0 0 0 0 0 0 0 28 20 242
2021/2022663 25 45 28 78 60 20 12 36 24 76 141 118
2022/2023780 82 116 47 107 50 61 18 48 130 35 63 23
2023/2024189 19 29 11 35 12 41 4 13 5 5 8 7
2024/2025583 39 70 52 55 78 23 32 25 35 40 19 115
2025/20261.279 117 85 91 86 143 59 148 88 353 109 0 0
Totale 5.004